Table 3 Baseline characteristics of patients stratified by SPPB
From: Frailty and physical function in chronic kidney disease: the CanFIT study
Variable | SPPB ≥ 10 (N = 95) | SPPB < 10 (N = 122) | P-Value |
|---|---|---|---|
Age (years) | 62.9 (52.9–72.3) | 74.6 (63.4–82.5) | <0.0001 |
Gender (Female) | 27 (29.4 %) | 57 (48.3 %) | 0.0054 |
Weight (kg) | 81.2 (72–95.9) | 86.1 (71.7–96.6) | 0.3352 |
Systolic Blood Pressure (mmHg) | 135 (123–149) | 140 (126–151) | 0.2047 |
Diastolic Blood Pressure (mmHg) | 78 (68–85) | 71 (65–78) | 0.0008 |
Pulse Pressure (mmHg) | 59 (48–70) | 69.5 (57–79) | <0.0001 |
Laboratory Values | |||
eGFR (mL/min/1.73 m2) | 18 (13–26) | 20 (16–27) | 0.0901 |
Creatinine (umol/L) | 273.5 (202–404) | 229 (186–309) | 0.0273 |
Log Urine ACR | 3.3 (1.1–5) | 3.3 (0.9–5.2) | 0.7659 |
Hemoglobin (g/L) | 118 (110–126) | 113 (105–122) | 0.0107 |
Hemoglobin A1c (%) | 5.9 (5.5–7.5) | 6.8 (5.8–8.1) | 0.0014 |
Blood Glucose (mmol/L) | 6.2 (5.3–8.5) | 7.3 (5.5–9.9) | 0.0793 |
Comorbidities | |||
Visual / Hearing Impairment | 32 (33.7 %) | 69 (56.6 %) | 0.0008 |
Hypertension | 76 (80.0 %) | 105 (89.0 %) | 0.0682 |
Dyslipidemia | 55 (57.9 %) | 78 (67.2 %) | 0.1617 |
Diabetes (Type I or II) | 40 (42.1 %) | 88 (75.2 %) | <0.0001 |
Previous MI | 5 (5.3 %) | 24 (20.5 %) | 0.0013 |
Congestive Heart Failure | 5 (5.3 %) | 26 (22.2 %) | 0.0005 |
Neurologic Disease | 12 (12.6 %) | 39 (33.3 %) | 0.0005 |